J. Heaton et al., PULMONARY VASODILATION TO ADRENOMEDULLIN - A NOVEL PEPTIDE IN HUMANS, American journal of physiology. Heart and circulatory physiology, 37(6), 1995, pp. 2211-2215
The present study investigates the effects of human adrenomedullin (AD
M) on the pulmonary vascular bed of isolated, blood-perfused rat lung.
Because pulmonary blood flow and left atrial pressure were constant,
changes in pulmonary arterial pressure directly reflect changes in pul
monary vascular resistance. Under conditions of resting (low) pulmonar
y vasomotor tone, intra-arterial bolus injections of ADM(1-52) and two
truncated sequences of ADM-(1-52) [ADM(1-12) and ADM-(13-52)] did not
alter pulmonary arterial pressure. When pulmonary vasomotor tone was
increased by U-46619, a thromboxane A(2) mimic, intra-arterial bolus i
njections of ADM-(1-52) and ADM-(13-52) at similar doses produced simi
lar, dose-dependent reductions in pulmonary arterial pressure. On a mo
lar basis, ADM-(1-52) had greater pulmonary vasodilator activity than
isoproterenol. In contrast, ADM-(1-12) had no activity. When pulmonary
vasomotor tone was actively increased to the same level using KCl, th
e pulmonary vasodilator activity of ADM-(13-52) was decreased 10-fold.
The present data demonstrate that ADM-(1-52) dilates the pulmonary va
scular bed and suggest that the pulmonary vasodilator activity of ADM
is greater on pulmonary blood vessels preconstricted through a recepto
r-dependent mechanism. Because meclofenamate, nitro-L-arginine methyl
ester, methysergide, BW A-1433U83, U-37883A, and calcitonin gene-relat
ed peptide [CGRP-(8-37)], a CGRP-receptor antagonist, did not alter th
e pulmonary vasodilator response to ADM-(1-52), the present data sugge
st that ADM dilates the pulmonary vascular bed independently of cycloo
xygenase products, endothelium-derived relaxation factor, serotoninerg
ic receptors, adenosine(1) purinoreceptors, ATP-dependent potassium ch
annels, and CGRP receptors. Furthermore, only a fragment of the ADM mo
lecule is necessary to dilate the pulmonary vascular bed. The present
data suggest that ADM may represent a novel regulatory peptide in the
lung.